Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2021-2027

Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2016-2027)
2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Regions
2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal antibodies (mAbs) Biosimilars Industry Dynamic
2.3.1 Monoclonal antibodies (mAbs) Biosimilars Market Trends
2.3.2 Monoclonal antibodies (mAbs) Biosimilars Market Drivers
2.3.3 Monoclonal antibodies (mAbs) Biosimilars Market Challenges
2.3.4 Monoclonal antibodies (mAbs) Biosimilars Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue
3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2016-2021)
3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue
3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio
3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2020
3.5 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served
3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type
4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2022-2027)
5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application
5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027)
6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
6.2.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021)
6.2.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027)
6.2.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027)
6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
6.3.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021)
6.3.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027)
6.3.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027)
6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
6.4.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021)
6.4.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027)
7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
7.2.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027)
7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
7.3.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027)
7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
7.4.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
8.2.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
8.3.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region
8.4.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027)
9.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
9.2.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027)
9.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
9.3.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027)
9.4 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
9.4.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
10.2.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
10.3.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
10.4.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Biocon Business Overview
11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction
11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.1.5 Biocon Recent Development
11.2 Celltrion
11.2.1 Celltrion Company Details
11.2.2 Celltrion Business Overview
11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction
11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.2.5 Celltrion Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 Hospira
11.4.1 Hospira Company Details
11.4.2 Hospira Business Overview
11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction
11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.4.5 Hospira Recent Development
11.5 3SBio
11.5.1 3SBio Company Details
11.5.2 3SBio Business Overview
11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction
11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.5.5 3SBio Recent Development
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Details
11.6.2 Accord Healthcare Business Overview
11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction
11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.6.5 Accord Healthcare Recent Development
11.7 AET Biotech
11.7.1 AET Biotech Company Details
11.7.2 AET Biotech Business Overview
11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.7.5 AET Biotech Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Allergan Business Overview
11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction
11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.8.5 Allergan Recent Development
11.9 Amega Biotech
11.9.1 Amega Biotech Company Details
11.9.2 Amega Biotech Business Overview
11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
11.9.5 Amega Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Erythropoietin (EPO)
Table 3. Key Players of Human Growth Hormone (HGH)
Table 4. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Key Players of Monoclonal Antibody (mAb)
Table 6. Key Players of Insulin
Table 7. Key Players of Interferon (IFN)
Table 8. Key Players of Others
Table 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2016-2021)
Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2022-2027)
Table 15. Monoclonal antibodies (mAbs) Biosimilars Market Trends
Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Drivers
Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Challenges
Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Restraints
Table 19. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2016-2021)
Table 21. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2020)
Table 22. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
Table 26. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2021)
Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2016-2021)
Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million)
Table 66. Biocon Company Details
Table 67. Biocon Business Overview
Table 68. Biocon Monoclonal antibodies (mAbs) Biosimilars Product
Table 69. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 70. Biocon Recent Development
Table 71. Celltrion Company Details
Table 72. Celltrion Business Overview
Table 73. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product
Table 74. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 75. Celltrion Recent Development
Table 76. Dr. Reddy's Laboratories Company Details
Table 77. Dr. Reddy's Laboratories Business Overview
Table 78. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product
Table 79. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 80. Dr. Reddy's Laboratories Recent Development
Table 81. Hospira Company Details
Table 82. Hospira Business Overview
Table 83. Hospira Monoclonal antibodies (mAbs) Biosimilars Product
Table 84. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 85. Hospira Recent Development
Table 86. 3SBio Company Details
Table 87. 3SBio Business Overview
Table 88. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product
Table 89. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 90. 3SBio Recent Development
Table 91. Accord Healthcare Company Details
Table 92. Accord Healthcare Business Overview
Table 93. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product
Table 94. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 95. Accord Healthcare Recent Development
Table 96. AET Biotech Company Details
Table 97. AET Biotech Business Overview
Table 98. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product
Table 99. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 100. AET Biotech Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 104. Allergan Recent Development
Table 105. Amega Biotech Company Details
Table 106. Amega Biotech Business Overview
Table 107. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product
Table 108. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million)
Table 109. Amega Biotech Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2020 VS 2027
Figure 2. Erythropoietin (EPO) Features
Figure 3. Human Growth Hormone (HGH) Features
Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features
Figure 5. Monoclonal Antibody (mAb) Features
Figure 6. Insulin Features
Figure 7. Interferon (IFN) Features
Figure 8. Others Features
Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2020 VS 2027
Figure 10. Anti-Cancer Case Studies
Figure 11. Anti-Inflammatory/Autoimmune Case Studies
Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions: 2020 VS 2027
Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2022-2027)
Figure 17. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2020
Figure 18. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2020
Figure 20. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2021)
Figure 21. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2022-2027)
Figure 22. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027)
Figure 24. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027)
Figure 25. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027)
Figure 26. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027)
Figure 30. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027)
Figure 31. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027)
Figure 32. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2016-2027)
Figure 42. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027)
Figure 50. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027)
Figure 51. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027)
Figure 52. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027)
Figure 58. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 62. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 63. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 64. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 65. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 66. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 67. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 68. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 69. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs